Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways

Cell and Tissue Research

Volumn 348, Issue 1, 2012, Pages 71-80

  Saha, Sarama ^a   Bornstein, Stefan R ^a   Graessler, Juergen ^a   Kopprasch, Steffi ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aldosterone; Aldosterone synthase; Janus kinase; MAP kinase; VLDL

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; JANUS KINASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADRENAL CORTEX CELL; ALDOSTERONE RELEASE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; TRANSCRIPTION REGULATION;

ADRENAL CORTEX; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANTIGENS, CD36; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JANUS KINASE 2; LIPOPROTEINS, VLDL; MAP KINASE SIGNALING SYSTEM; OXIDATION-REDUCTION; PHOSPHOPROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84859442063     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1346-3     Document Type: Article

References (35)

1. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H, Borén J (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755-765 (Pubitemid 43357551)
2. Adiels M, Olofsson SO, Taskinen MR, Borén J (2008) Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:1225-1236
3. Ansurudeen I, Pietzsch J, Graessler J, Ehrhart-Bornstein M, Saha S, Bornstein SR, Kopprasch S (2010) Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein. Am J Hypertens 23(10):1061-1068
4. Birkenkamp KU, Tuyt LML, Lummen C, Wierenga ATJ, Kruijer W, Vellenga W (2000) The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br J Pharmacol 131 (1):99-107
5. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M (2002) Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90:270-276 (Pubitemid 34633927)
6. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL (2008) Lipoprotein management in patients with cardiometabolic risk. Diabetes Care 31(4):811-822
7. Calvo D, Gómez-Coronado D, Suárez Y, Lasunción MA, Vega MA (1998) Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39:777-788 (Pubitemid 28163280)
8. Capponi AM (2002) Regulation of cholesterol supply for mineralo-corticoid biosynthesis. Trends Endocrinol Metab 13(3):118-121
9. Cushley RJ, Okon M (2002) NMR studies of lipoprotein structure. Annu Rev Biophys Biomol Struct 31:177-206 (Pubitemid 34666830)
10. Dinkel RE, Barrett PHR, Demant T, Parhofer KG (2006) In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects. Nutr Metab Cardiovasc Dis 16:215-221
11. Frias MA, James RW, Wicht CG, Lang U (2009) Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc Res 82:313-323
12. Graessler J, Pietzsch J, Westendorf T, Julius U, Bornstein SR, Kopprasch S (2007) Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor γ gene expression in macrophages. Diabetologia 50:1080-1088 (Pubitemid 46559268)
13. Gwynne JT, Hess B (1980) The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis. J Biol Chem 255(22):10875-10883 (Pubitemid 11171743)
14. Higashijima M, Nawata H, Kato K, Ibayashi H (1987) Studies on lipoprotein and adrenal steroidogenesis: I. Roles of low density lipoprotein- and high density lipoprotein-cholesterol in steroid production in cultured human adrenocortical cells. Endocrinol Jpn 34(5):635-645 (Pubitemid 19001416)
15. Hoekstra M, Korporaal SJA, Li Z, Zhao Y, Eck MV, Berkel TJCV (2010) Plasma lipoproteins are required for both basal and stress-induced adrenal glucocorticoid synthesis and protection against endotoxemia in mice. Am J Physiol Endocrinol Metab 299(6): E1038-E1043
16. Hu J, Zhang Z, Shen WJ, Azhar S (2010) Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab 7(47):1-25
17. Kannel WB, Vasan RS (2009) Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol 24(4):345-350
18. Kraemer FB (2007) Adrenal cholesterol utilization. Mol Cell Endocrinol 265-266:42-45
19. Krug AW, Ehrhart-Bornstein M (2008) Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension 51:1252-1258 (Pubitemid 351555932)
20. Laemmly UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
21. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478 (Pubitemid 20279989)
22. Li J, Feltzer RE, Dawson KL, Hudson EA, Clark BJ (2003) Janus Kinase 2 and calcium are required for angiotensinII-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells. J Biol Chem 278(52):52355-52362 (Pubitemid 38035825)
23. Maeba R, Shimasaki H, Ueta N (1994) Conformational changes in oxidized LDL recognized by mouse peritoneal macrophages. Biochim Biophys Acta 1215:79-86 (Pubitemid 24345058)
24. Nieland TJF, Chroni A, Fitzgerald ML, Maliga Z, Zannis VI, Kirchhausen T, Krieger M (2004) Cross-inhibition of SR-BIand ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res 45:1256-1265 (Pubitemid 38802628)
25. Nofer JR, Fobker M, Höbbel G, Voss R, Wolinska I, Tepel M, Zidek W, Junker R, Seedorf U, von Eckardstein A, Assmann G, Walter M (2000) Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid: involvement in mitogenesis but not in cholesterol efflux. Biochemistry 39:15199-15207
26. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular' function. Trends Pharmacol Sci 27:402-409 (Pubitemid 44069585)
27. Pietzsch J, Subat S, Nitzsche S, Leonhardt W, Schentke KU, Hanefeld M (1995) Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta 1254:77-88
28. Quinn SJ, Williams GH (1988) Regulation of aldosterone secretion. Annu Rev Physiol 50:409-426 (Pubitemid 18088113)
29. Richards JS (2001) New signaling pathways for hormones and cyclic adenosine 3',5'-monophosphate action in endocrine cells. Mol Endocrinol 15(2):209-218
30. Sachinidis A, Kettenhofen R, Seewald S, Gouni-Berthold I, Schmitz U, Seul C, Ko Y, Vetter H (1999) Evidence that lipoproteins are carriers of bioactive factors. Arterioscler Thromb Vasc Biol 19 (10):2412-2421 (Pubitemid 29477843)
31. Schmitt JM, Stork PJ (2002) Gα and Gβγ require distinct Srcdependent pathways to activate Rap1 and Ras. J Biol Chem 277:43024-43032 (Pubitemid 35285683)
32. Stillemark-Billton P, Beck C, Borén J, Olofsson SO (2005) Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2. J Lipid Res 46:104-114 (Pubitemid 40066676)
33. Xing Y, Cohen A, Rothblat G, Sankaranarayanan S, Weibel G, Royer L, Francone OL, Rainey WE (2011) Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone aynthase (CYP11B2). Endocrinology 152 (3):751-763
34. Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212-216
35. Zheng X, Bollag WB (2003) AngII induces transient phospholipase D activity in the H295R glomerulosa cell model. Mol Cell Endocrinol 206(1-2):113-122 (Pubitemid 37011256)